In this story
The drugs explicitly developed to treat rare diseases are more expensive.
an Reuters The price of the newly launched pharmaceuticals was more than doubled last year compared to 2021. Pharmaceuticals, which treat the rare diseases, usually get higher prices.
According to a Reuters survey on 45 pharmaceuticals, the medium annual prices of the new drugs were over $ 370,000 in 2024.
According to the IQVIA Data Science Institute, the proportion of drugs fired on orphanage has influenced less than 200,000 Americans, rising from 51%in 2019 in 2024 to 72%.IQV-0.26%) And reported by Reuters. More than 40% of the orphan launches were for cancer treatment.
The most expensive new drug in 2024 was developed by Orchard Pharmaceuticals and treated a genetic disabled methacroma -blooded non -profit. The drug costs more than $ 4 million a year for patients.
Tinglong Dai, a professor of operational management and business analysis at Johns Hopkins University’s Carey Business School, says Quartz is not surprised by the cost increase but can do more to help people who need drugs.
He said he wanted to see “Netflix.”NFLX-0.32%) In order to set the price, the model of the price promotes between the state and the pharmaceutical manufacturer, or the model of the patient, experts, policymakers and insurance companies that set prices, and he added that such agreements can still maintain drug companies while maintaining drugs.
However, according to DAI, even if the new drug is insured, the patient’s story is not necessarily over.
“Now that you are guaranteed now does not mean you get it. You have to pay a lot of money and insurance.” “We make it unnecessarily complicated.”
The current GPL-1 boom can also have a ripple effect of drug companies receiving more treatment for rare diseases and spending more money.
DAI said, “Everyone is looking for Daum Ozempic, and he has found that other niche drugs can be developed and there is a“ outflow effect ”that can treat more diseases and lifestyle problems.
“What can lead to many drug development is to see who will receive the next miracle drug.”
